{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:51:30Z","timestamp":1789411890752,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Residency Training Program Department of Pathology University of British Columbia"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1038\/s41379-021-00920-9","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T15:10:41Z","timestamp":1631113841000},"page":"77-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Significance of p53 immunostaining in mesothelial proliferations and correlation with TP53 mutation status"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7799-7860","authenticated-orcid":false,"given":"Julia R.","family":"Naso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8739-3879","authenticated-orcid":false,"given":"Basile","family":"Tessier-Cloutier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Senz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Huntsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4851-8517","authenticated-orcid":false,"given":"Andrew","family":"Churg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-021-00920-9_bib1","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/path.5375","article-title":"p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies","volume":"250","author":"Singh","year":"2020","journal-title":"J. Pathol."},{"key":"10.1038\/s41379-021-00920-9_bib2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/PGP.0000000000000274","article-title":"An immunohistochemical algorithm for ovarian carcinoma typing","volume":"35","author":"K\u00f6bel","year":"2016","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1038\/s41379-021-00920-9_bib3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/cjp2.53","article-title":"Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma","volume":"2","author":"K\u00f6bel","year":"2016","journal-title":"J. Pathol. Clin. Res."},{"key":"10.1038\/s41379-021-00920-9_bib4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/cncy.20071","article-title":"The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions","volume":"118","author":"Hasteh","year":"2010","journal-title":"Cancer Cytopathol"},{"key":"10.1038\/s41379-021-00920-9_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/ajcp\/110.2.191","article-title":"The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining","volume":"110","author":"Mangano","year":"1998","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1038\/s41379-021-00920-9_bib6","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.5858\/arpa.2012-0112-RA","article-title":"The separation of benign and malignant mesothelial proliferations","volume":"136","author":"Churg","year":"2012","journal-title":"Arch. Pathol. Lab. Med"},{"key":"10.1038\/s41379-021-00920-9_bib7","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/2159-8290.CD-18-0804","article-title":"Integrative molecular characterization of malignant pleural mesothelioma","volume":"8","author":"Hmeljak","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1038\/s41379-021-00920-9_bib8","first-page":"100232","article-title":"Genomic characterization of malignant pleural mesothelioma and associated clinical outcomes","volume":"25","author":"Markowitz","year":"2020","journal-title":"Cancer Treat. Res. Commun"},{"key":"10.1038\/s41379-021-00920-9_bib9","doi-asserted-by":"crossref","unstructured":"Pagano, M. et al. Mutational profile of malignant pleural mesothelioma (MPM) in the phase II RAMES Study. Cancers12https:\/\/doi.org\/10.3390\/cancers12102948 (2020).","DOI":"10.3390\/cancers12102948"},{"key":"10.1038\/s41379-021-00920-9_bib10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000507373","article-title":"Mutational profiling of driver tumor suppressor and oncogenic genes in Brazilian malignant pleural mesotheliomas","volume":"87","author":"Campanella","year":"2020","journal-title":"Pathobiology"},{"key":"10.1038\/s41379-021-00920-9_bib11","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920971421","article-title":"Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma","volume":"12","author":"Yang","year":"2020","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1038\/s41379-021-00920-9_bib12","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1038\/s41379-020-0588-y","article-title":"Molecular characterization of diffuse malignant peritoneal mesothelioma","volume":"33","author":"Hung","year":"2020","journal-title":"Mod. Pathol."},{"key":"10.1038\/s41379-021-00920-9_bib13","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/1878-0261.12651","article-title":"Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival","volume":"14","author":"Quetel","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1038\/s41379-021-00920-9_bib14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2559.2006.02442.x","article-title":"Sensitivity and specificity of immunohistochemical antibodies used to distinguish between benign and malignant pleural disease: a systematic review of published reports","volume":"49","author":"King","year":"2006","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00920-9_bib15","doi-asserted-by":"crossref","unstructured":"Salisbury, T. & Churg, A. CD146 immunohistochemical staining for the separation of benign from malignant mesothelial proliferations. Virchows Arch.https:\/\/doi.org\/10.1007\/s00428-021-03077-7 (2021).","DOI":"10.1007\/s00428-021-03077-7"},{"key":"10.1038\/s41379-021-00920-9_bib16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/path.2744","article-title":"The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas","volume":"222","author":"K\u00f6bel","year":"2010","journal-title":"J. Pathol."},{"key":"10.1038\/s41379-021-00920-9_bib17","doi-asserted-by":"crossref","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/s41379-021-00920-9_bib18","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/s41379-020-0524-1","article-title":"Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status","volume":"33","author":"Tessier-Cloutier","year":"2020","journal-title":"Mod. Pathol."},{"key":"10.1038\/s41379-021-00920-9_bib19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1365-2559.2003.01686.x","article-title":"The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2","volume":"43","author":"Attanoos","year":"2003","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00920-9_bib20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1309\/XL6K-8E62-9FLD-V8Q8","article-title":"Immunohistochemical analysis still has a limited role in the diagnosis of malignant mesothelioma. A study of thirteen antibodies","volume":"116","author":"Roberts","year":"2001","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1038\/s41379-021-00920-9_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/(SICI)1096-9896(199910)189:2<251::AID-PATH412>3.0.CO;2-F","article-title":"The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis","volume":"189","author":"Cury","year":"1999","journal-title":"J. Pathol."},{"key":"10.1038\/s41379-021-00920-9_bib22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2559.1992.tb00403.x","article-title":"p53 expression is common in malignant mesothelioma","volume":"21","author":"Kafiri","year":"1992","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00920-9_bib23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/path.1711680407","article-title":"p53 immunostaining in the distinction between benign and malignant mesothelial proliferations using formalin-fixed paraffin sections","volume":"168","author":"Mayall","year":"1992","journal-title":"J. Pathol."},{"key":"10.1038\/s41379-021-00920-9_bib24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/path.1711680406","article-title":"Immunoreactivity for p53 protein in malignant mesothelioma and non-neoplastic mesothelium","volume":"168","author":"Ramael","year":"1992","journal-title":"J. Pathol."},{"key":"10.1038\/s41379-021-00920-9_bib25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0046-8177(94)90115-5","article-title":"p53 immunostaining in the differentiation of reactive processes from malignancy in pleural biopsy specimens","volume":"25","author":"Cagle","year":"1994","journal-title":"Hum. Pathol."},{"key":"10.1038\/s41379-021-00920-9_bib26","first-page":"733","article-title":"p53 immunostaining in differential diagnosis of pleural mesothelial proliferations","volume":"17","author":"Esposito","year":"1997","journal-title":"Anticancer Res."},{"key":"10.1038\/s41379-021-00920-9_bib27","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1097\/PAS.0000000000001565","article-title":"The separation of benign and malignant mesothelial proliferations: new markers and how to use them","volume":"44","author":"Churg","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1038\/s41379-021-00920-9_bib28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.5858\/arpa.2019-0370-OA","article-title":"Use of programmed death ligand-1 (PD-L1) staining to separate sarcomatoid malignant mesotheliomas from benign mesothelial reactions","volume":"144","author":"Derakhshan","year":"2020","journal-title":"Arch. Pathol. Lab. Med"},{"key":"10.1038\/s41379-021-00920-9_bib29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat. Genet."},{"issue":"Suppl 1","key":"10.1038\/s41379-021-00920-9_bib30","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1097\/PGP.0000000000000488","article-title":"Interpretation of p53 immunohistochemistry in endometrial carcinomas: toward increased reproducibility","volume":"38","author":"K\u00f6bel","year":"2019","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1038\/s41379-021-00920-9_bib31","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2217\/fon.13.261","article-title":"Mdm2 protein expression is strongly associated with survival in malignant pleural mesothelioma","volume":"10","author":"Mairinger","year":"2014","journal-title":"Future Oncol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41379-021-00920-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-021-00920-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222003532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222003532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-021-00920-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:31:15Z","timestamp":1760229075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222003532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0893395222003532"],"URL":"https:\/\/doi.org\/10.1038\/s41379-021-00920-9","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Significance of p53 immunostaining in mesothelial proliferations and correlation with TP53 mutation status","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-021-00920-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}